TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹765 Cr | ₹501 Cr | ₹445 Cr | ₹393 Cr | ₹369 Cr |
What is the latest Long Term Provisions ratio of TORRENT PHARMACEUTICALS ?
| Year | Long Term Provisions |
|---|---|
| Mar2026 | ₹765 Cr |
| Mar2025 | ₹501 Cr |
| Mar2024 | ₹445 Cr |
| Mar2023 | ₹393 Cr |
| Mar2022 | ₹369 Cr |
How is Long Term Provisions of TORRENT PHARMACEUTICALS Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2026 | ₹765 Cr | 52.52 | |
| Mar2025 | ₹501 Cr | 12.72 | |
| Mar2024 | ₹445 Cr | 13.14 | |
| Mar2023 | ₹393 Cr | 6.60 | |
| Mar2022 | ₹369 Cr | - | |
Compare Long Term Provisions of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹187,156.8 Cr | -1.9% | -1.9% | 33.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,952.0 Cr | 1% | -2.9% | 17.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹230,427.0 Cr | 1.8% | 17% | 39.7% | Stock Analytics | |
| CIPLA | ₹114,715.0 Cr | 0.3% | 0.7% | -7.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,409.9 Cr | 1.7% | 3.5% | -4.1% | Stock Analytics | |
| MANKIND PHARMA | ₹97,756.1 Cr | -1% | -7.2% | -4.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -1.9% |
-1.9% |
33.2% |
| SENSEX | 0.5% |
2.1% |
-4.5% |
You may also like the below Video Courses